Dark
Light
System
Institutional Investment Manager
Cormorant Asset Management, LP
Cormorant Asset Management, LP (CIK: 0001583977) incorporated in Delaware, located at 200 Clarendon Street, Boston, MA. Institutional holdings reported to the SEC.

Institutional Holdings (2015Q3)
Portfolio Summary: 87 holdings with a total value of $626,096,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 HERON THERAPEUTICS INC 1,685,719 41,132,000 6.57%
2 ALKERMES PLC SHS 700,000 41,069,000 6.56%
3 NEUROCRINE BIOSCIE COM USD0.001 718,900 28,605,000 4.57%
4 DYAX CORP COM CVR 1,400,000 26,726,000 4.27%
5 ARDELYX INC COM 1,481,075 25,593,000 4.09%
6 ALDER BIOPHARMACEUTICALS INC 757,475 24,815,000 3.96%
7 EAGLE PHARMACEUTICALS INC COM 300,000 22,209,000 3.55%
8 OMEROS CORP 1,960,000 21,482,000 3.43%
9 PORTOLA PHARMACEUTICALS INC 500,000 21,310,000 3.40%
10 SORRENTO THERAPEUTICS INC COM NEW 2,095,334 17,580,000 2.81%
11 QUOTIENT LTD 1,119,100 14,548,000 2.32%
12 DYNAVAX TECHNOLOGIES CORP 575,000 14,111,000 2.25%
13 DEXCOM 153,000 13,137,000 2.10%
14 BIOCRYST PHARMACEUTICALS 1,080,000 12,312,000 1.97%
15 NEVRO CORP 265,386 12,311,000 1.97%
16 TESARO INC 291,250 11,679,000 1.87%
17 COHERUS BIOSCIENCES INC COM 569,130 11,405,000 1.82%
18 NOVAVAX INC COM 1,600,000 11,312,000 1.81%
19 ALNYLAM PHARMACEUTICALS INC 140,000 11,250,000 1.80%
20 ULTRAGENYX PHARMACEUTICAL INC COM 109,500 10,546,000 1.68%
21 SAGE THERAPEUTICS 240,000 10,157,000 1.62%
22 CHINA BIOLOGIC PRODS INC 111,500 10,015,000 1.60%
23 COLLEGIUM PHARMACEUTICAL INC COM 450,000 9,950,000 1.59%
24 SOCIETAL CDMO INC 780,000 9,383,000 1.50%
25 PFENEX INC COM 624,900 9,380,000 1.50%
26 MIRATI THERAPEUTICS INC COM 255,000 8,777,000 1.40%
27 ROCKWELL MED INC COM 1,105,000 8,520,000 1.36%
28 ADVAXIS INC COM NEW 800,000 8,184,000 1.31%
29 FORWARD PHARMA A/S 335,068 7,894,000 1.26%
30 LIPOCINE INC NEW 666,666 7,887,000 1.26%
31 SERES THERAPEUTICS INC 250,000 7,410,000 1.18%
32 AGENUS INC 1,559,000 7,171,000 1.15%
33 MINERVA NEUROSCIENCES INC COM 1,145,043 6,011,000 0.96%
34 REGULUS THERAPEUTICS INC 896,522 5,863,000 0.94%
35 Curis, Inc 2,632,000 5,317,000 0.85%
36 ZYNERBA PHARMACEUTICALS INC 356,600 5,103,000 0.82%
37 ACCELERON PHARMA 200,000 4,980,000 0.80%
38 Atara Biotherapeutics Inc 150,000 4,716,000 0.75%
39 Aptose Biosciences Inc Com New 1,081,867 4,713,000 0.75%
40 Intec Pharma Ltd 800,000 4,480,000 0.72%
41 NEKTAR THERAPEUTICS COM 397,500 4,357,000 0.70%
42 DERMIRA INC 170,000 3,968,000 0.63%
43 EPIRUS BIOPHARMA 896,600 3,963,000 0.63%
44 ARRAY BIOPHARMA INC COM 850,000 3,876,000 0.62%
45 KITE PHARMA INCORPORATED 68,800 3,831,000 0.61%
46 REGENXBIO INC COM 156,741 3,453,000 0.55%
47 EPIZYME INC COM 266,250 3,424,000 0.55%
48 KARYOPHARM THERAPEUTICS INC COM 300,987 3,169,000 0.51%
49 CELYAD SA 75,000 3,139,000 0.50%
50 Lion Biotechnologies 499,815 2,879,000 0.46%
Page 1 of 2

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-15-041700, filed 2015.11.16).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.